Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Nanomedicine

• Publication date

  2016-07-07

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.2217/nnm-2016-5000PMID 27389568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells

  2016cited by this paper
• Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells.

  2015cited by this paper
• Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.

  2015cited by this paper
• Lipid Raft-Mediated Regulation of Hyaluronan–CD44 Interactions in Inflammation and Cancer

  2015cited by this paper
• Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption.

  2015cited by this paper
• Supramolecular Organization and siRNA Binding of Hyaluronic Acid-Coated Lipoplexes for Targeted Delivery to the CD44 Receptor.

  2015cited by this paper
• Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art.

  2014cited by this paper
• Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells.

  2014cited by this paper
• Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.

  2014cited by this paper
• Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles.

  2014cited by this paper
• Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.

  2014cited by this paper
• Hyaluronan: biosynthesis and signaling.

  2014cited by this paper
• Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.

  2014cited by this paper
• Aptamer-functionalized nanoparticles for drug delivery.

  2014cited by this paper
• Lipid-based nanoparticles in the systemic delivery of siRNA.

  2014cited by this paper
• Hyaluronan Polymer Length, Grafting Density, and Surface Poly(ethylene glycol) Coating Influence in Vivo Circulation and Tumor Targeting of Hyaluronan-Grafted Liposomes

  2014cited by this paper
• Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin

  2014cited by this paper
• Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.

  2014cited by this paper
• Chemically Modified N-Acylated Hyaluronan Fragments Modulate Proinflammatory Cytokine Production by Stimulated Human Macrophages*

  2014cited by this paper
• Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.

  2014cited by this paper
• Chemoenzymatic Synthesis of Oligohyaluronan–Lipid Conjugates

  2014cited by this paper
• Modulation of drug resistance in ovarian adenocarcinoma using chemotherapy entrapped in hyaluronan-grafted nanoparticle clusters.

  2014cited by this paper
• Drug carriers for the delivery of therapeutic peptides.

  2014cited by this paper
• Advances and advantages of nanomedicine in the pharmacological targeting of hyaluronan-CD44 interactions and signaling in cancer.

  2014cited by this paper
• A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases.

  2014cited by this paper
• Colon cancer: cancer stem cells markers, drug resistance and treatment.

  2014cited by this paper
• Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.

  2014cited by this paper
• Cell uptake of paclitaxel solid lipid nanoparticles modified by cell-penetrating peptides in A549 cells.

  2013cited by this paper
• Liposomal drug delivery systems: from concept to clinical applications.

  2013cited by this paper
• Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells

  2013cited by this paper
• Lipid-Based Nanoparticles in Cancer Diagnosis and Therapy

  2013cited by this paper
• Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery

  2013cited by this paper
• Immune responses of therapeutic lipid nanoparticles

  2013cited by this paper
• Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity.

  2013cited by this paper
• A daunting task: manipulating leukocyte function with RNAi

  2013cited by this paper
• In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker

  2013cited by this paper
• Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection.

  2013cited by this paper
• Hyaluronic acid-coated liposomes for active targeting of gemcitabine.

  2013cited by this paper
• Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells.

  2013cited by this paper
• Protein-Nanoparticle Interactions

  2013cited by this paper
• Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.

  2013cited by this paper
• Hyperthermia-induced drug targeting

  2013cited by this paper
• Current trends in the use of liposomes for tumor targeting.

  2013cited by this paper
• Liposomal Amphotericin B

  2012cited by this paper
• The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.

  2012cited by this paper
• Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.

  2012cited by this paper
• STABILITY OF NANOPARTICLE SUSPENSIONS IN DIFFERENT BIOLOGICALLY RELEVANT MEDIA

  2012cited by this paper
• Dextran and Protamine-Based Solid Lipid Nanoparticles as Potential Vectors for the Treatment of X-Linked Juvenile Retinoschisis

  2012cited by this paper
• Lipid nanoparticles for cancer therapy: state of the art and future prospects

  2012cited by this paper
• Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery

  2012cited by this paper
• Hyaluronan-modi fi ed and regular multilamellar liposomes provide subcellular targeting to macrophages , without eliciting a pro-in fl ammatory response

  2012cited by this paper
• Liposomes for intravitreal drug delivery: a state of the art.

  2012cited by this paper
• Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor.

  2012cited by this paper
• Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response.

  2012cited by this paper
• Consecutive targetable smart nanoprobe for molecular recognition of cytoplasmic microRNA in metastatic breast cancer.

  2012cited by this paper
• Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound.

  2012cited by this paper
• Toxicological profile of therapeutic nanodelivery systems.

  2012cited by this paper
• Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives.

  2012cited by this paper
• Lipid raft/caveolae signaling is required for Cryptococcus neoformans invasion into human brain microvascular endothelial cells

  2012cited by this paper
• Doxil®--the first FDA-approved nano-drug: lessons learned.

  2012cited by this paper
• The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering

  2012cited by this paper
• Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.

  2011cited by this paper
• Hyaluronan as an immune regulator in human diseases.

  2011cited by this paper
• Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis

  2011cited by this paper
• Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes.

  2011cited by this paper
• Understanding the Dual Nature of CD44 in Breast Cancer Progression

  2011cited by this paper
• Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers.

  2011cited by this paper
• Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody.

  2011cited by this paper
• Hyaluronan–CD44 interactions as potential targets for cancer therapy

  2011cited by this paper
• Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.

  2011cited by this paper
• Synthesis and evaluation of stearylated hyaluronic acid for the active delivery of liposomes to liver endothelial cells.

  2011cited by this paper
• Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.

  2011cited by this paper
• Leukemia stem cells and microenvironment: biology and therapeutic targeting.

  2011cited by this paper
• Aptamer-conjugated nanomaterials and their applications.

  2011cited by this paper
• CD44, a therapeutic target for metastasising tumours.

  2010cited by this paper
• Cell adhesion molecule CD44: its functional roles in prostate cancer.

  2010cited by this paper
• Receptor-targeted nanocarriers for therapeutic delivery to cancer

  2010cited by this paper
• Revitalizing membrane rafts: new tools and insights

  2010cited by this paper
• Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.

  2010cited by this paper
• Dispersion and stability optimization of TiO2 nanoparticles in cell culture media.

  2010cited by this paper
• Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors.

  2010cited by this paper
• The enzymatic degradation of hyaluronan is associated with disease progression in experimental pulmonary hypertension.

  2010cited by this paper
• Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells

  2009cited by this paper
• Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium.

  2009cited by this paper
• Biomolecular Characterization of CD44-Fibrin(ogen) Binding

  2009cited by this paper
• Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.

  2009cited by this paper
• Understanding biophysicochemical interactions at the nano-bio interface.

  2009cited by this paper
• Hyaluronic Acid-Modified DOTAP/DOPE Liposomes for the Targeted Delivery of Anti-Telomerase siRNA to CD44-Expressing Lung Cancer Cells

  2009cited by this paper
• Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma

  2009cited by this paper
• Nanocarriers’ entry into the cell: relevance to drug delivery

  2009cited by this paper
• Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

  2009cited by this paper
• Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution

  2009cited by this paper
• Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering

  2008cited by this paper
• Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

  2008cited by this paper
• CD44 is of Functional Importance for Colorectal Cancer Stem Cells

  2008cited by this paper
• Hyaluronidases in cancer biology.

  2008cited by this paper
• Pancreatic Cancer Stem Cells: Implications for the Treatment of Pancreatic Cancer

  2008cited by this paper
• Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.

  2008cited by this paper
• Liposomes with Triggered Content Release for Cancer Therapy

  2008cited by this paper
• Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.

  2008cited by this paper

• Exploring nanocomposite materials in clinical dermatology: Innovations for treating skin diseases

  2025cites this paper
• Hyaluronic acid-conjugated lipid nanocarriers in advancing cancer therapy: A review.

  2025cites this paper
• Mucoadhesive hyaluronic acid composites for prolonged gastric retention.

  2025cites this paper
• Hyaluronic acid-modified epigallocatechin gallate nanoliposomes:Preparation and evaluation of the stability and anticancer activity

  2025cites this paper
• Enhancing chemosensitivity and reducing cancer stem-like cell population using doxorubicin-loaded polyelectrolyte nanocapsules

  2024cites this paper
• Hyaluronic acid-modified liposomes Potentiated in-vivo anti-hepatocellular carcinoma of icaritin

  2024cites this paper
• Multifunctional Liposomes Co-Modified with Ginsenoside Compound K and Hyaluronic Acid for Tumor-Targeted Therapy

  2024cites this paper
• Cd44 Targeted Plga Nano-Medicine For Cancer Chemotherapy- A Comprehensive Review

  2023cites this paper
• Light‐Enhanced Hypoxia‐Responsive Gene Editing for Hypoxia‐Resistant Photodynamic and Immunotherapy

  2023cites this paper
• Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes.

  2022cites this paper
• Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways.

  2022cites this paper
• Surface Modification of Lipid-Based Nanoparticles.

  2022cites this paper
• Novel CD44-targeting and pH/redox-dual-stimuli-responsive core–shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis

  2021cites this paper
• Novel CD44-Targeting and pH/redox Dual-Stimuli Responsive Core-Shell Nanoparticles Loading Triptolide to Combat Breast Cancer Growth and Lung Metastasis

  2021cites this paper
• Systematic Review of Cancer Targeting by Nanoparticles Revealed a Global Association between Accumulation in Tumors and Spleen

  2021cites this paper
• Recent progress of graphene oxide-based multifunctional nanomaterials for cancer treatment

  2021cites this paper
• Enzyme-responsive polysaccharide supramolecular nanoassembly for enhanced DNA encapsulation and controlled release

  2021cites this paper
• Semiconducting polymer nanoparticles for photothermal ablation of colorectal cancer organoids

  2021cites this paper
• Interactions between Cationic Ion Pair Amphiphile Vesicles and Hyaluronan-A Physicochemical Study.

  2021cites this paper
• Repurposing of Fluvastatin as an Anticancer Agent against Breast Cancer Stem Cells via Encapsulation in a Hyaluronan-Conjugated Liposome

  2020cites this paper
• Immune cell engineering: opportunities in lung cancer therapeutics

  2020cites this paper
• Cytomembrane-mimicking nanocarriers with a scaffold consisting of a CD44-targeted endogenous component for effective asparaginase supramolecule delivery.

  2020cites this paper
• Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells.

  2020cites this paper
• Hyaluronic acid modified liposomes for targeted delivery of doxorubicin and paclitaxel to CD44 overexpressing tumor cells with improved dual-drugs synergistic effect

  2019cites this paper
• Cancer drug resistance: rationale for drug delivery systems and targeted inhibition of HSP90 family proteins

  2019cites this paper
• Biomedical Applications of Hyaluronic Acid-Based Nanomaterials in Hyperthermic Cancer Therapy

  2019cites this paper
• Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness

  2019cites this paper
• Biomedical application of graphene: From drug delivery, tumor therapy, to theranostics.

  2019cites this paper
• CD44 targeted PLGA nanomedicines for cancer chemotherapy

  2018cites this paper
• Nanomedicines for dysfunctional macrophage-associated diseases.

  2017cites this paper
• Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone‐Responsive Human Breast Cancer

  2017cites this paper
• The Potential of Zebrafish as a Model Organism for Improving the Translation of Genetic Anticancer Nanomedicines

  2017cites this paper
• Antiproliferative Activity and VEGF Expression Reduction in MCF7 and PC-3 Cancer Cells by Paclitaxel and Imatinib Co-encapsulation in Folate-Targeted Liposomes

  2017cites this paper
• Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy

  2017influential citation
• Redox‐sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models

  2017cites this paper
• Polysaccharide-coated liposomes by post-insertion of a hyaluronan-lipid conjugate.

  2017cites this paper
• Heat shock proteins and cancer: How can nanomedicine be harnessed?

  2017cites this paper
• Cyclodextrin-mesoporous silica particle composites for controlled antibiotic release. A proof of concept toward colon targeting.

  2017cites this paper
• Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.

  2017cites this paper
• Chitosan and hyaluronan coated liposomes for pulmonary administration of curcumin.

  2017cites this paper